Brian L. Pessin Net Worth

The estimated Net Worth of Brian L. Pessin is at least $265 Tausend dollars as of 27 July 2017. Brian Pessin owns over 30,000 units of Immucell stock worth over $265,300 and over the last 7 years Brian sold ICCC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Brian Pessin ICCC stock SEC Form 4 insiders trading

Brian has made over 1 trades of the Immucell stock since 2017, according to the Form 4 filled with the SEC. Most recently Brian bought 30,000 units of ICCC stock worth $157,500 on 27 July 2017.

The largest trade Brian's ever made was buying 30,000 units of Immucell stock on 27 July 2017 worth over $157,500. On average, Brian trades about 30,000 units every 0 days since 2017. As of 27 July 2017 Brian still owns at least 70,000 units of Immucell stock.

You can see the complete history of Brian Pessin stock trades at the bottom of the page.

What's Brian Pessin's mailing address?

Brian's mailing address filed with the SEC is 310 EAST 75TH STREET, APT. 2A, NEW YORK, NY, 10021.

Insiders trading at Immucell

Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin und Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.

What does Immucell do?

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.

Complete history of Brian Pessin stock trades at Immucell

Immucell executives and stock owners

Immucell executives and other stock owners filed with the SEC include:

• Michael F. Brigham,
  Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director
• Michael Brigham,
  President, Chief Executive Officer, Treasurer, Secretary, Director
• Bobbi Brockmann,
  Vice President - Sales and Marketing, Director
• Elizabeth Williams,
  Vice President - Manufacturing Operations
• Elizabeth L. Williams,
  VP of Manufacturing Operations
• Dr. Joseph H. Crabb Ph.D.,
  VP & Chief Scientific Officer
• Joseph Crabb,
  Chief Scientific Officer, Vice President
• David Tomsche,
  Chairman of the Board
• Paul Wainman,
  Independent Director
• Jonathan Rothschild,
  Independent Director
• Steven Rosgen,
  Independent Director
• David Cunningham,
  Independent Director
• John W. Zinckgraf,
  Director of Product Devel.
• A. Gustavo Scaffa,
  Sr. Director of Quality
• Elizabeth S. Toothaker,
  Director of Fin. & Admin.
• Linda Rhodes,
  Director
• Brian L. Pessin,
  
• Norman H Pessin,
  
• Gloria F Basse,
  Director
• Anthony B Cashen,
  Director
• Robert C Bruce,
  Director
• William H Maxwell,
  Director
• Bryan K. Gathagan,